(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 22.71% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.6%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.39%.
Clearpoint Neuro's revenue in 2026 is $42,279,000.On average, 5 Wall Street analysts forecast CLPT's revenue for 2026 to be $1,653,207,086, with the lowest CLPT revenue forecast at $1,554,495,408, and the highest CLPT revenue forecast at $1,723,183,783. On average, 5 Wall Street analysts forecast CLPT's revenue for 2027 to be $1,994,427,370, with the lowest CLPT revenue forecast at $1,793,648,548, and the highest CLPT revenue forecast at $2,174,798,864.
In 2028, CLPT is forecast to generate $2,398,913,420 in revenue, with the lowest revenue forecast at $2,304,838,384 and the highest revenue forecast at $2,469,469,697.